Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06863285

Asthma Control Through Telemedicine

The purpose of this research study is to evaluate the impact of pharmacist led educational interventions on Asthmatic patients, and also determine their medication adherence.

Pharmacist's intervention aims to answer:

1. How a pharmacist intervention program impact medication adherence in persistent asthma? 2. To assess how pharmacist led educational intervention like patients' counseling and medication reminders through Telemedicine have an impact on patient's asthma control? 3. Which mode of communication (Verbal instructions, videos and pamphlets) for the patient counselling is most beneficial for the patients in asthma control.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Asthmatic Patients Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

11 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hamdard University

Islamabad, Punjab Province, 44000, Pakistan

About this study

This is a randomized, pharmacist-led, two-group, longitudinal descriptive interventional study performed through in person (Public and private hospitals) and telecommunication (WhatsApp, network calls and messaging). The investigator will use snowball method to approach patients through telecommunication. Recruited patients will be randomly divided into two groups: the Control and the experimental group. The Control Group will not receive any intervention, and experimental group will receive special counseling about persistent asthma, it's medications and medical devices, their appropriate use, and side effects. Using Telemedicine as message and call reminders to increase medication adherence and improve their asthmatic condition. The intervention will be conducted for one month on the experimental group according to the recruitment date and time of the patients.

Pre-validated questionnaires will be used for the assessment

  • The adherence to asthma medication questionnaire (AAMQ-13).
  • Asthma Control test TM (ACT).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age above 11 years.
  • Persistent Asthma Patient.
  • Patients taking medications and inhaler.
  • Patient who will consent for the study.
  • Patient with basic telecommunication facility.
  • Patient who responded to messages and calls.

Exclusion criteria

  • Patients who will refuse to participate in study will not be included.
  • Irresponsive patients to messages and calls

Treatment and study plan

educational

Other

intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications

  • Pharmacist counseling patients regarding their disease and severity
  • Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication.
  • Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises.

pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.

Primary outcomes

  1. Asthma Control Score

    Time frame: 1 month

    Patient health related outcomes that is level of asthma control is measured by pre-validated tool Asthma Control test TM (ACT).

    The Asthma Control Test™ assess responsiveness to changes in asthma control over time.

    The tool has 5 questions with each having options with scores 1,2,3,4, and 5. A SCORE OF 19 OR LESS might be a warning of the need for further evaluation to determine whether adjustments to asthma treatment regimens or other measures are required to improve asthma control. If score is 15 or less, asthma may be poorly controlled or not controlled at all.

  2. Patients Medication Adherence Score

    Time frame: 1 month

    The primary aim of this study will be to evaluate the effectiveness/impact of a pharmacist educational intervention on medication adherence in Asthmatic patients.

    Adherence will be measured using the adherence to asthma medication questionnaire (AAMQ-13 The AAMQ-13 is a reliable and valid questionnaire with several desirable characteristics as it has a high internal validity, good criterion validity, and strong construct validity. The AAMQ-13 is a suitable questionnaire that can identify non-adherent patients and reveal the reasons behind their non-adherence (intentional or unintentional non-adherence). Each question has Always, Often, sometimes, rarely and never response with scores allotted as 1,2,3,4 and 5 respectively, Score interpretation is as follows for the given tool Poor adherence Score= 13-29 Moderate adherence Score= 30-47 Excellent adherence= 48-65

Study contacts

Contact information is provided by the study sponsor or research team.

MUhammad Abubakar, PhD

CONTACT

[email protected]

+923237166544

Matti Ullah, PhD

CONTACT

[email protected]

0092-51-8840000 ext. 5119

Sponsors and collaborators

Lead sponsor

Hamdard University

Other

Registry information

Official study title

The Pharmacist Led Educational Interventions Through Telemedicine to Improve Asthma Control: a Randomized Control Trial

Acronym: PLET-I

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 7, 2025
Registry last updated
Mar 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.